IP Library Granted Patent US 9,115,289
Granted Patent B2
US 9,115,289 · App. 13/148,286 · Granted Aug 25, 2015

Multibranched bioadhesive compounds and synthetic methods therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,289
App. No.
13/148,286
Granted
Aug 25, 2015
Kind
B2
Abstract

The invention describes new synthetic medical adhesives and antifouling coatings which exploit the key components of natural marine mussel adhesive proteins.

Claims (116)

1. A compound comprising the formula (I)

wherein

each L a , L c , L e , L g and L i , independently, is a linker;

each L k and L m , independently, is a linker or a suitable linking group selected from amine, amide, ether, ester, urea, carbonate or urethane linking groups;

each X, X 3 , X 5 , X 7 , X 9 , X 11 , X 13 and X 15 , independently, is an oxygen atom or NR;

R, if present, is H or a branched or unbranched C1-10 alkyl group;

each R 1 , R 3 , R 5 , R 7 , R 9 , R 11 , R 13 and R 15 , independently, is a branched or unbranched C1-C15 alkyl group;

each DHPD xx and DHPD dd , independently, is a multihydroxy phenyl derivative residue;

ee is a value from 1 to about 80;

gg is a value from 0 to about 80:

ii is a value from 0 to about 80;

kk is a value from 0 to about 80;

mm is a value from 0 to about 80;

oo is a value from 1 to about 120;

qq is a value from 1 to about 120;

ss is a value from 1 to about 120;

uu is a value from 1 to about 120; and

vv is a value from 1 to about 80.

2. The compound of claim 1 , wherein L a is a residue of a C1-C15, alkyl anhydride or activated dicarbonyl moiety, a poly(ethyleneglycol) bis(carboxymethyl)ether, polyethylene glycol or an amino acid.

3. The compound of claim 2 , wherein the dicarbonyl moiety is a residue of succinic acid or the amino acid is glycine.

4. The compound of claim 1 , wherein L c is a residue of a C1-C15 alkyl lactone or lactam, a poly C1-C15 alkyl lactone or lactam, a polyester, or a compound comprising the formula Y 4 —R 17 —C(═O)—Y 6 ,

wherein Y 4 is OH, NHR, a halide, or an activated derivative of OH or NHR;

R 17 is a branched or unbranched C1-C15 alkyl group; and

Y 6 is NHR, a halide, or OR.

5. The compound of claim 4 , wherein the polylactone is a polycaprolactone.

6. The compound of claim 1 , wherein L e is a residue of an alkylene diol, an alkylene diamine or a poly(alkylene oxide) polyether or derivative thereof.

7. The compound of claim 6 , wherein L e is a poly(alkylene oxide) or —O—CH 2 CH 2 —O—CH 2 CH 2 —O—.

8. The compound of claim 1 , wherein L g or L c is a residue of a C1-C15 alkyl lactone or lactam, a poly C1-C15 alkyl lactone or lactam, or a compound comprising the formula Y 4 —R 17 —C(═O)—Y 6 ,

wherein Y 4 is OH, NHR, a halide, or an activated derivative of OH or NHR;

R 17 is a branched or unbranched C1-C15 alkyl group; and

Y 6 is NHR, a halide, or OR.

9. The compound of claim 8 , wherein the polylactone is polycaprolactone.

10. The compound of claim 1 , wherein L i is a residue of a C1-C15 alkyl anhydride or activated dicarbonyl moiety, a poly(ethyleneglycol) bis(carboxymethyl)ether or an amino acid.

11. The compound of claim 10 , wherein L i is a residue of succinic acid or glycine.

12. The compound of claim 1 , wherein X, X 7 , X 11 and X 15 are each O or NH.

13. The compound of claim 1 , wherein R 1 , R 7 , R 11 and R 15 are each —CH 2 CH 2 —.

14. The compound of claim 1 , wherein X 3 , X 5 , X 9 and X 13 are each O.

15. The compound of claim 1 , wherein R 3 , R 5 , R 9 and R 13 are each —CH 2 —.

16. The compound of claim 1 , wherein L k and L m form an amide, ester or carbamate.

17. The compound of claim 1 , wherein each DHPD xx and DHPD dd , independently, is a residue of a formula comprising:

wherein Q is an OH;

“z” is 2 to 5;

each X 1 , independently, is H, NH 2 , OH, or COOH;

each Y 1 , independently, is H, NH 2 , OH, or COOH;

each X 2 , independently, is H, NH 2 , OH, or COOH;

each Y 2 , independently, is H, NH 2 , OH, or COOH;

Z is COOH, NH 2 , OH or SH;

aa is a value of 0 to about 4;

bb is a value of 0 to about 4; and

optionally provided that when one of the combinations of X 1 and X 2 , Y 1 and Y 2 , X 1 and Y 2 or Y 1 and X 2 are absent, then a double bond is formed between the C aa and C bb , further provided that aa and bb are each at least 1 to form the double bond when present.

18. The compound of claim 1 , wherein DHPD xx and DHPD dd residues are from 3,4-dihydroxy phenylalanine (DOPA), 3,4-dihydroxyphenethylamine (dopamine), 3,4-dihydroxyhydrocinnamic acid (DOHA), 3,4-dihydroxyphenyl ethanol, 3,4 dihydroxyphenylacetic acid, 3,4 dihydroxyphenylamine, or 3,4-dihydroxybenzoic acid.

19. The compound of claim 1 , wherein

L a is a residue of succinic acid;

L c is a residue of a polycaprolactone, a caprolactone, a polylactic acid, a polylactone or a lactic acid or lactone;

L e is a residue of a polyethylene glycol;

L g is a residue of a polycaprolactone, a caprolactone, a polylactic acid, a polylactone or a lactic acid or lactone;

L i is a residue of succinic anhydride;

X, X 7 , X 11 and X 15 are each O or NH;

R 1 , R 7 , R 11 and R 15 are each —CH 2 CH 2 —;

X 3 , X 5 , X 9 and X 13 are each O;

R 3 , R 5 , R 9 and R 13 are each —CH 2 —;

L k and L m form an amide; and

DHPD xx and DHPD dd are residues from 3,4-dihydroxyhydrocinnamic acid (DOHA).

20. The compound of claim 1 , wherein

L a is a residue of glycine;

L c is a residue of a polycaprolactone, a caprolactone, a polylactic acid, a polylactone or a lactic acid or lactone;

L e is a residue of a polyethylene glycol;

L g is a residue of a polycaprolactone, a caprolactone, a polylactic acid, a polylactone or a lactic acid or lactone;

L i is a residue of glycine;

X, X 7 , X 11 and X 15 are each O or NH;

R 1 , R 7 , R 11 and R 15 are each —CH 2 CH 2 —;

X 3 , X 5 , X 9 and X 13 are each O;

R 3 , R 5 , R 9 and R 13 are each —CH 2 —;

L k and L m form a carbamate; and

DHPD xx and DHPD dd are residues from 3,4 dihydroxyphenylethylamine.

21. The compound of claim 1 , wherein

L a is a residue of a poly(ethyleneglycol) bis(carboxymethyl)ether;

L c , L e , L g , and L, are absent;

ee is a value from 1 to about 11;

gg, ii, kk, and mm are each independently 0;

X, X 7 , X 11 and X 15 are each O or NH;

R 1 , R 7 , R 11 and R 15 are each —CH 2 CH 2 —;

X 3 , X 5 , X 9 and X 13 are each O;

R 3 , R 5 , R 9 and R 13 are each —CH 2 —;

L k and L m form an amide; and

DHPD xx and DHPD dd are residues from 3,4-dihydroxyhydrocinnamic acid (DOHA).

22. A bioadhesive construct, comprising:

a support suitable for tissue repair or reconstruction; and

a coating comprising a multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 .

23. The bioadhesive construct of claim 22 , further comprising an oxidant.

24. The bioadhesive construct of claim 22 , wherein the oxidant is formulated with the coating.

25. The bioadhesive construct of claim 22 , wherein the oxidant is applied to the coating.

26. The bioadhesive construct of claim 22 , wherein the support is a film, a mesh, a membrane, a nonwoven or a prosthetic.

27. A blend of a polymer and a compound of claim 1 .

28. The blend of claim 27 , wherein the polymer is present in a range of about 1 to about 50 percent by weight.

29. The blend of claim 28 , wherein the polymer is present in a range of about 1 to about 30 percent by weight.

30. A bioahesive construct comprising:

a support suitable for tissue repair or reconstruction; and

a coating comprising the blend of claim 27 .

31. The bioadhesive construct of claim 30 , further comprising an oxidant.

32. The bioadhesive construct of claim 30 , wherein the oxidant is formulated with the coating.

33. The bioadhesive construct of claim 30 , wherein the oxidant is applied to the coating.

34. The bioadhesive construct of claim 30 , wherein the support is a film, a mesh, a membrane, a nonwoven or a prosthetic.

35. A bioadhesive construct comprising:

a support suitable for tissue repair or reconstruction;

a first coating comprising a multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 and a polymer; and

a second coating coated onto the first coating, wherein the second coating comprises a multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 .

36. A bioadhesive construct comprising:

a support suitable for tissue repair or reconstruction;

a first coating comprising a first multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 and a first polymer; and

a second coating coated onto the first coating, wherein the second coating comprises a second multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 and a second polymer, wherein the first and second polymer may be the same or different and wherein the first and second DHPp can be the same or different.

37. A bioadhesive construct comprising:

a support suitable for tissue repair or reconstruction;

a first coating comprising a first multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 ; and

a second coating coated onto the first coating, wherein the second coating comprises a second multihydroxyphenyl (DHPD) functionalized polymer (DHPp) of claim 1 , wherein the first and second DHPp can be the same or different.

38. The compound of claim 20 , wherein L c is a residue of a polycaprolactone and L g is a residue of a polycaprolactone.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2018
From: KENSEY NASH CORP.
To: DSM IP ASSETS B.V.
Reel/Frame 044985/0395 →
MERGER Recorded Mar 10, 2014
From: KNC NER ACQUISITION SUB, INC.
To: KENSEY NASH CORPORATION
Reel/Frame 032394/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2011
From: LEE, BRUCE P.; SILVARY, SUNIL; MURPHY, JOHN L.
To: KNC NER ACQUISITION SUB, INC.
Reel/Frame 026903/0633 →